Compare BDTX & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | RMM |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 285.6M |
| IPO Year | 2020 | 2019 |
| Metric | BDTX | RMM |
|---|---|---|
| Price | $2.14 | $14.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.40 | N/A |
| AVG Volume (30 Days) | ★ 564.6K | 46.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.45 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $12.55 |
| 52 Week High | $4.94 | $14.88 |
| Indicator | BDTX | RMM |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 52.35 |
| Support Level | $1.93 | $13.82 |
| Resistance Level | $2.67 | $14.79 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 26.76 | 45.90 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.